company background image
IMR logo

Imricor Medical Systems CHIA:IMR Stock Report

Last Price

AU$0.44

Market Cap

AU$89.3m

7D

-2.2%

1Y

41.9%

Updated

15 Jun, 2024

Data

Company Financials +

Imricor Medical Systems, Inc.

CHIA:IMR Stock Report

Market Cap: AU$89.3m

IMR Stock Overview

A medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States.

IMR fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Imricor Medical Systems, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Imricor Medical Systems
Historical stock prices
Current Share PriceAU$0.44
52 Week HighAU$0.85
52 Week LowAU$0.30
Beta0.27
1 Month Change-1.12%
3 Month Change-14.98%
1 Year Change41.94%
3 Year Change-75.69%
5 Year Changen/a
Change since IPO-69.44%

Recent News & Updates

Recent updates

Shareholder Returns

IMRAU Medical EquipmentAU Market
7D-2.2%-2.0%-1.7%
1Y41.9%19.9%7.0%

Return vs Industry: IMR exceeded the Australian Medical Equipment industry which returned 19.9% over the past year.

Return vs Market: IMR exceeded the Australian Market which returned 7% over the past year.

Price Volatility

Is IMR's price volatile compared to industry and market?
IMR volatility
IMR Average Weekly Movement9.1%
Medical Equipment Industry Average Movement9.4%
Market Average Movement8.7%
10% most volatile stocks in AU Market16.4%
10% least volatile stocks in AU Market3.2%

Stable Share Price: IMR's share price has been volatile over the past 3 months.

Volatility Over Time: IMR's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2006n/aSteve Wedanwww.imricor.com

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company’s principal product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning.

Imricor Medical Systems, Inc. Fundamentals Summary

How do Imricor Medical Systems's earnings and revenue compare to its market cap?
IMR fundamental statistics
Market capAU$89.26m
Earnings (TTM)-AU$34.20m
Revenue (TTM)AU$930.55k

95.9x

P/S Ratio

-2.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IMR income statement (TTM)
RevenueUS$615.57k
Cost of RevenueUS$1.73m
Gross Profit-US$1.12m
Other ExpensesUS$21.51m
Earnings-US$22.63m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.11
Gross Margin-181.27%
Net Profit Margin-3,675.61%
Debt/Equity Ratio-101.1%

How did IMR perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.